{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:34:03Z","timestamp":1769142843353,"version":"3.49.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":3336,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The prognostic implications of QRS duration and morphology in heart failure patients treated with cardiac resynchronization therapy (CRT) remains debated. The present evaluation investigated the association between QRS duration (&amp;lt;150 vs. \u2265150 ms) and QRS morphology (left bundle brand block [LBBB] vs. non-LBBB) and long-term prognosis of a large cohort of unselected heart failure patients treated with CRT according to contemporary guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Of 973 heart failure patients treated with CRT (mean age 66.1 \u00b1 9.8 years, 76% male), 658 patients (68%) showed QRS duration \u2265150 ms, and 772 patients (79%) had LBBB configuration. Compared with patients with QRS duration &amp;lt;150 ms, patients with QRS duration \u2265150 ms had less frequently ischaemic cardiomyopathy and atrial fibrillation and showed larger left ventricular volumes and lower left ventricular ejection fraction. Compared with patients with non-LBBB configuration, patients with LBBB morphology were younger, less often males and less often had ischaemic cardiomyopathy and atrial fibrillation. On multivariable analysis, after correcting for relevant clinical and echocardiographic variables, LBBB morphology was significantly associated with better survival [hazard ratio (HR) 0.737; 95% confidence interval (CI) 0.584\u20130.931; P = 0.010], whereas there was no statistically significant association between QRS duration \u2265150 ms and survival (HR 0.889; 95% CI 0.726\u20131.088; P = 0.252).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large population of heart failure patients treated with CRT, QRS morphology was independently associated with long-term survival. The association between QRS duration and long-term survival was not statistically significant.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12122","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T04:38:47Z","timestamp":1480567127000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["QRS Duration Versus Morphology and Survival After Cardiac Resynchronization Therapy"],"prefix":"10.1093","volume":"4","author":[{"given":"Mand J.H.","family":"Khidir","sequence":"first","affiliation":[{"name":"Heart Lung Center, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[{"name":"Heart Lung Center, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Ajmone Marsan","sequence":"additional","affiliation":[{"name":"Heart Lung Center, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Schalij","sequence":"additional","affiliation":[{"name":"Heart Lung Center, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[{"name":"Heart Lung Center, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2026012115134932500_ehf212122-bib-0001","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"2026012115134932500_ehf212122-bib-0002","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"2026012115134932500_ehf212122-bib-0003","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012115134932500_ehf212122-bib-0004","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"2026012115134932500_ehf212122-bib-0005","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/CIRCHEARTFAILURE.113.000380","article-title":"Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: results from the resynchronization-defibrillation for ambulatory heart failure trial (RAFT)","volume":"6","author":"Birnie","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012115134932500_ehf212122-bib-0006","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurjhf\/hfp074","article-title":"Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial","volume":"11","author":"Gervais","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026012115134932500_ehf212122-bib-0007","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","article-title":"Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT)","volume":"123","author":"Zareba","year":"2011","journal-title":"Circulation"},{"key":"2026012115134932500_ehf212122-bib-0008","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/archinternmed.2011.247","article-title":"Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials","volume":"171","author":"Sipahi","year":"2011","journal-title":"Arch Intern Med"},{"key":"2026012115134932500_ehf212122-bib-0009","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ahj.2011.11.014","article-title":"Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials","volume":"163","author":"Sipahi","year":"2012","journal-title":"Am Heart J"},{"key":"2026012115134932500_ehf212122-bib-0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jama.2013.8641","article-title":"QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy","volume":"310","author":"Peterson","year":"2013","journal-title":"JAMA"},{"key":"2026012115134932500_ehf212122-bib-0011","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/heartjnl-2012-303076","article-title":"Right ventricular function and survival following cardiac resynchronisation therapy","volume":"99","author":"Leong","year":"2013","journal-title":"Heart"},{"key":"2026012115134932500_ehf212122-bib-0012","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/eurheartj\/ehm305","article-title":"Guidelines for cardiac pacing and cardiac resynchronization therapy","volume":"28","author":"Vardas","year":"2007","journal-title":"Eur Heart J"},{"key":"2026012115134932500_ehf212122-bib-0013","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012115134932500_ehf212122-bib-0014","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2008.12.013","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee","volume":"53","author":"Surawicz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012115134932500_ehf212122-bib-0015","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"Can Med Assoc J"},{"key":"2026012115134932500_ehf212122-bib-0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCHEARTFAILURE.111.964221","article-title":"Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) Trial","volume":"5","author":"Rector","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026012115134932500_ehf212122-bib-0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging England"},{"key":"2026012115134932500_ehf212122-bib-0018","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2026012115134932500_ehf212122-bib-0019","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012115134932500_ehf212122-bib-0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amjcard.2009.12.018","article-title":"Value of tissue doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure","volume":"105","author":"Van Bommel","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026012115134932500_ehf212122-bib-0021","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026012115134932500_ehf212122-bib-0022","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2014.06.1162","article-title":"Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR","volume":"64","author":"Zusterzeel","year":"2014","journal-title":"J Am Coll Cardiol United States"},{"key":"2026012115134932500_ehf212122-bib-0023","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012115134932500_ehf212122-bib-0024","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jacc.2012.03.059","article-title":"Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration","volume":"60","author":"Dupont","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026012115134932500_ehf212122-bib-0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCEP.113.001299","article-title":"PR interval identifies clinical response in patients with non\u2013left bundle branch block: a multicenter automatic defibrillator implantation trial\u2013cardiac resynchronization therapy substudy","volume":"7","author":"Kutyifa","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012115134932500_ehf212122-bib-0026","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/CIRCULATIONAHA.109.894774","article-title":"Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy","volume":"121","author":"Sweeney","year":"2010","journal-title":"Circulation"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/4\/1\/23\/66225152\/eschf_4_1_23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/4\/1\/23\/66225152\/eschf_4_1_23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:18:43Z","timestamp":1769026723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/4\/1\/23\/8413111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,1]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12122","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2]]},"published":{"date-parts":[[2016,12,1]]},"assertion":[{"value":"2016-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}